Evidence map›Paper›PMID 39782766›Full record

ArticlemAbs2025

Predicting purification process fit of monoclonal antibodies using machine learning.

Andrew Maier, Minjeong Cha, Sean Burgess, Amy Wang, Carlos Cuellar, Soo Kim, Neeraja Sundar Rajan, Josephine Neyyan, Rituparna Sengupta, Kelly O'Connor and 2 more

Abstract read
In one paragraph

Article in mAbs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrew MaierDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.ORCID 0000-0001-7660-532X
Minjeong ChaDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Sean BurgessDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Amy WangDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.ORCID 0009-0000-1492-3867
Carlos CuellarDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Soo KimDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Neeraja Sundar RajanDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Josephine NeyyanDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Rituparna SenguptaDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.ORCID 0000-0002-2042-6047
Kelly O'ConnorDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Nicole OttDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.
Ambrose WilliamsDepartment of Purification, Microbiology and Virology, Genentech Inc, South San Francisco, CA, USA.ORCID 0000-0001-9896-1819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In early-stage development of therapeutic monoclonal antibodies, assessment of the viability and ease of their purification typically requires extensive experimentation. However, the work required for upstream protein expression and downstream purification development often conflicts with timeline pressures and material constraints, limiting the number of molecules and process conditions that can reasonably be assessed. Recently, high-throughput batch-binding screen data along with improved molecular descriptors have enabled development of robust quantitative structure-property relationship (QSPR) models that predict monoclonal antibody chromatographic binding behavior from the amino acid sequence. Here, we describe a QSPR strategy for

Indexed as

Antibodies, MonoclonalMachine LearningHumansPrincipal Component AnalysisQuantitative Structure-Activity RelationshipAntibodies, MonoclonalAntibodybiophysicalchromatographycomputationaldevelopabilitymachine learningmanufacturabilitypurificationQSARQSPR

Identifiers

PMID39782766
PMCPMC11730362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.